Stock Events

Stock Events

Collegium Pharmaceutical 

€29.8
0
-€0.2-0.67% Today

Statistics

Day High
29.8
Day Low
29.8
52W High
41.8
52W Low
23.4
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
1.3
1.47
1.64
1.81
Expected EPS
1.30056636
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 354.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing directly in the pain management market where Collegium also operates.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in various therapeutic areas including pain management, directly overlapping with Collegium's market.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie competes in the specialty pharmaceuticals space, including pain management with its products, which positions it as a competitor to Collegium.
AMGEN
AMGN
Mkt Cap178B
Amgen, a biotechnology company, has a portfolio that includes treatments for pain, making it a competitor in some of Collegium's key markets.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. competes across a broad range of therapeutic areas, including pain management through its innovative and generic drug offerings.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global pharmaceutical company with a diverse portfolio, including pain management solutions that compete with Collegium's products.
Pacira BioSciences
PCRX
Mkt Cap971.5M
Pacira Biosciences focuses on non-opioid pain management solutions, offering competitive alternatives to Collegium's opioid-based pain management products.

About

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Show more...
CEO
Mr. Vikram Karnani
Employees
357
Country
United States
ISIN
US19459J1043

Listings

STU
DE
354.STU
MU
DE
354.MU
XNAS
US
COLL
F
DE
354.F

0 Comments

Share your thoughts

FAQ

What is Collegium Pharmaceutical stock price today?▼
The current price of 354.STU is €29.8 EUR — it has decreased by -0.67% in the past 24 hours. Watch Collegium Pharmaceutical stock price performance more closely on the chart.
What is Collegium Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Collegium Pharmaceutical stocks are traded under the ticker 354.STU.
Is Collegium Pharmaceutical stock price growing?▼
354.STU stock has risen by +3.47% compared to the previous week, the month change is a +7.19% rise, over the last year Collegium Pharmaceutical has showed a +27.35% increase.
When is the next Collegium Pharmaceutical earnings date?▼
Collegium Pharmaceutical is going to release the next earnings report on May 07, 2026.
What were Collegium Pharmaceutical earnings last quarter?▼
354.STU earnings for the last quarter are 1.73 EUR per share, whereas the estimation was 1.81 EUR resulting in a -4.64% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Collegium Pharmaceutical have?▼
As of May 06, 2026, the company has 357 employees.
In which sector is Collegium Pharmaceutical located?▼
Collegium Pharmaceutical operates in the Health & Wellness sector.
When did Collegium Pharmaceutical complete a stock split?▼
Collegium Pharmaceutical has not had any recent stock splits.
Where is Collegium Pharmaceutical headquartered?▼
Collegium Pharmaceutical is headquartered in Stoughton, United States.